You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

VIBISONE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Vibisone, and when can generic versions of Vibisone launch?

Vibisone is a drug marketed by Fresenius Kabi Usa and is included in one NDA.

The generic ingredient in VIBISONE is cyanocobalamin. There are nine drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the cyanocobalamin profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Vibisone

A generic version of VIBISONE was approved as cyanocobalamin by PADAGIS ISRAEL on September 9th, 2020.

  Subscribe

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for VIBISONE?
  • What are the global sales for VIBISONE?
  • What is Average Wholesale Price for VIBISONE?
Summary for VIBISONE
Drug patent expirations by year for VIBISONE
Pharmacology for VIBISONE
Drug ClassVitamin B12

US Patents and Regulatory Information for VIBISONE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fresenius Kabi Usa VIBISONE cyanocobalamin INJECTABLE;INJECTION 080557-003 Approved Prior to Jan 1, 1982 AP RX Yes Yes ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

VIBISONE Market Analysis and Financial Projection Experimental

Market Dynamics and Financial Trajectory for the Drug: Vibisone

Introduction

Vibisone, though not as widely discussed as some other pharmaceuticals, is part of a broader market segment that includes vitamins and supplements. To understand its market dynamics and financial trajectory, we need to delve into the larger context of the vitamin market, particularly focusing on vitamin B12, which is closely related to Vibisone.

Vitamin B12 Market Overview

The global vitamin B12 market provides a relevant backdrop for analyzing Vibisone. Here are some key points:

  • Market Size and Growth: The global vitamin B12 market is projected to grow from $205.0 million in 2024 to $346.6 million by 2032, at a Compound Annual Growth Rate (CAGR) of 6.8% during the forecast period[4].

  • Market Segments: The market is segmented by type, application, and end-user. Understanding these segments can help in identifying the niche where Vibisone operates[4].

Market Drivers

Several factors drive the growth of the vitamin B12 market, which can indirectly influence the trajectory of Vibisone:

  • Increasing Health Awareness: Growing awareness about health and wellness, particularly among the aging population and those with dietary restrictions, drives the demand for vitamin B12 supplements[4].

  • Dietary Deficiencies: The prevalence of vitamin B12 deficiency, especially in vegetarians and vegans, contributes to the market growth[4].

  • Therapeutic Uses: Vitamin B12 is used in various therapeutic applications, including the treatment of anemia and neurological disorders, which further boosts its demand[4].

Financial Trajectory

While specific financial data for Vibisone is not readily available, we can infer its potential financial trajectory based on the broader vitamin B12 market:

  • Revenue Growth: Given the overall growth of the vitamin B12 market, it is reasonable to expect that products like Vibisone could see increased revenue. For instance, the global vitamin B12 market value stood at $194.3 million in 2023 and is expected to reach $346.6 million by 2032[4].

  • Market Penetration: As health awareness and the demand for supplements increase, Vibisone could benefit from higher market penetration. This is particularly true if the product is well-positioned in terms of marketing, distribution, and pricing.

Competitive Landscape

The competitive landscape of the vitamin B12 market is crucial for understanding Vibisone's financial trajectory:

  • Key Players: The market is competitive, with several key players. Vibisone would need to differentiate itself through quality, pricing, and marketing to gain a significant market share[4].

  • Product Differentiation: Any unique features or benefits of Vibisone, such as higher bioavailability or specific formulations, could help it stand out in a crowded market.

Regulatory Environment

The regulatory environment plays a significant role in the financial trajectory of any pharmaceutical or supplement product:

  • Compliance: Ensuring compliance with regulatory standards is crucial. Non-compliance can lead to significant financial penalties and damage to the brand[5].

  • Approval Processes: The process of obtaining approvals and certifications can be costly and time-consuming. Successful navigation of these processes is essential for market entry and growth.

Consumer Trends

Consumer trends can significantly impact the financial performance of Vibisone:

  • Health and Wellness: The growing trend towards health and wellness is a positive indicator for vitamin B12 supplements. Consumers are increasingly seeking products that support their overall health, which could drive demand for Vibisone[4].

  • Sustainability and Natural Products: There is a rising preference for natural and sustainable products. If Vibisone is positioned as a natural or sustainably sourced product, it could attract a loyal customer base.

Challenges and Opportunities

Like any product in the pharmaceutical or supplement market, Vibisone faces both challenges and opportunities:

  • Challenges: Competition, regulatory hurdles, and the need for continuous innovation are significant challenges. Additionally, the market is sensitive to economic fluctuations and changes in consumer preferences[4].

  • Opportunities: The growing demand for health supplements, the potential for expansion into new markets, and the opportunity to differentiate through unique formulations or delivery methods are all positive factors[4].

Key Takeaways

  • Market Growth: The vitamin B12 market is expected to grow significantly, driven by health awareness and dietary deficiencies.
  • Financial Potential: Vibisone could benefit from this growth, especially if it is well-positioned in the market.
  • Regulatory Compliance: Ensuring compliance with regulatory standards is crucial for market success.
  • Consumer Trends: Aligning with consumer trends towards health, wellness, and sustainability can drive demand.

FAQs

Q: What is the projected growth rate of the global vitamin B12 market? A: The global vitamin B12 market is projected to grow at a CAGR of 6.8% from 2024 to 2032[4].

Q: What are the main drivers of the vitamin B12 market? A: The main drivers include increasing health awareness, dietary deficiencies, and therapeutic uses[4].

Q: How does the competitive landscape affect Vibisone? A: Vibisone needs to differentiate itself through quality, pricing, and marketing to gain a significant market share in a competitive market[4].

Q: What role does regulatory compliance play in the financial trajectory of Vibisone? A: Ensuring compliance with regulatory standards is crucial to avoid financial penalties and ensure market entry and growth[5].

Q: How can Vibisone benefit from consumer trends? A: By aligning with trends towards health, wellness, and sustainability, Vibisone can attract a loyal customer base and drive demand[4].

Sources

  1. IQVIA, "Finding the growth engines of the endocrine & metabolic ...", October 2023.
  2. Chemical Reviews, "Metallodrugs in Medicinal Inorganic Chemistry", January 2014.
  3. Baron Capital Group, "A Multi-Billion-Dollar Drug Market", March 2024.
  4. Fortune Business Insights, "Vitamin B12 Market Size, Share, Growth | Industry Report [2032]".
  5. North Carolina Department of Environmental Quality, "wi0500805_deemed files_20150309".

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.